Details
Description
This article describes the findings of a study conducted to evaluate baseline glucose assessment among youth ages 2 through 18 starting a second-generation antipsychotic in the United States.
This article describes the findings of a study conducted to evaluate baseline glucose assessment among youth ages 2 through 18 starting a second-generation antipsychotic in the United States.